The Washington Rheumatology Alliance is convening the Rheumatology Care Alliance Learning Collaborative. The collaborative is preparing practices around Washington State for New Payment Models and Standards of Care in Managing Patients with Rheumatoid Arthritis across the entire care cycle.
In the Learning Collaborative, five participating sites from across the state are given resources and support for shifting to new payment models and standards of care. Objectives of the Learning Collaborative include:
- Improved care coordination: training and support for integrating a real-time decision support and population health system, allowing for enhanced identification of early-stage patients, streamlined referrals, and overall enhanced quality of treatment.
- A shared learning environment: through a series of monthly webinars and a dedicated training module, Participating Providers will be able to exchange strategies and experiences as they work to improve quality and care coordination, test approaches and design care processes that are relevant to their clinical and operational models.
- Support for new reimbursement models: Participating Providers will receive training and resources around meeting the standards of the National Center for Quality Assurance’s Patient Centered Specialty Program (PCSP).
The Learning Collaborative begins in June and includes that following activities:
- Series of 6 monthly interactive educational webinars
- Training on NCQA standards through an e-portal platform
- Access to tools to improve quality tracking
- Case study reports of best practices and challenges from the participating sites
Results of the Collaborative
The results from the collaborative will be shared at the Rheumatology Learning Collaborative Report Forum in early 2018. The presentation will include case studies from the Learning Collaborative practice sites that demonstrate the transformation of their practice and improved care delivery that was implemented following the collaborative. The event is open to members of the Rheumatology community, including providers, payers, administrators and pharmaceutical representatives. Look for more details on that coming soon. If you are interested in attending, email firstname.lastname@example.org.
This project would not be possible without the generous support from our key sponsors: